Oscar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on September 11, 2023. The filing serves as a Regulation FD disclosure regarding an upcoming presentation by CEO Mark T. Bertolini at the Morgan Stanley 21st Annual Global Healthcare Conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of a corporate event rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the schedule for a business update presentation.
Guidance, Outlook, and Management Commentary
- Event: CEO Mark T. Bertolini is scheduled to present at the Morgan Stanley 21st Annual Global Healthcare Conference on September 11, 2023, beginning at approximately 8:00 a.m. ET.
- Outlook: The Company expects to reaffirm its full-year 2023 outlook across all metrics, consistent with the financial results press release issued on August 8, 2023.
- Access: The presentation will be available via virtual webcast on the investor relations website (ir.hioscar.com), with a replay available for 90 days.
- Risks: The filing includes standard cautionary language regarding forward-looking statements, noting that actual results may differ materially due to risks and uncertainties detailed in the Company's Form 10-Q for the period ended June 30, 2023.
Investor Verification Checklist
- Verify the full-year 2023 outlook details in the August 8, 2023, Q2 earnings press release.
- Review the "Risk Factors" section of the Form 10-Q filed for the quarter ended June 30, 2023.
- Confirm the webcast replay availability on the investor relations website if the live event is missed.